Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy-Reference-Cited by-同舟云学术

Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy

Published:2022-01 Issue: Volume:Volume 14 Page:377-386
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Yuan Chengliang,Huang Meifang,Wang Huilin,Jiang Wei,Su Cuiyun,Zhou Shaozhang

Publisher

Informa UK Limited

Subject

Oncology

Reference39 articles.

1. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

2. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

3. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

4. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

5. Immune checkpoint inhibitors for first‐line treatment of advanced non‐small‐cell lung cancer: A systematic review and network meta‐analysis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinoma;2024-08-18

2. Prognostic value of fibrinogen change value in adrenocortical carcinoma patients;Discover Oncology;2024-07-30

3. Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer;Frontiers in Oncology;2024-06-24

4. Novel prognostic score based on the preoperative total bilirubin-albumin ratio and fibrinogen-albumin ratio in ampullary adenocarcinoma;World Journal of Gastrointestinal Surgery;2023-10-27

5. The Effect of Liraglutide on Lung Cancer and Its Potential Protective Effect on High Glucose-Induced Lung Senescence and Oxidative Damage;Frontiers in Bioscience-Landmark;2023-10-24